FindTrial
Sign In

Management of Patients with Hepatobiliary or Pancreatic Malignancies: A Cohort Study

Management of Patients with Hepatobiliary or Pancreatic Malignancies: A Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068239
Enrollment
Unknown
Registered
2023-02-10
Start date
2022-09-16
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatobiliary and Pancreatic Malignancies

Interventions

Hepatobiliary and Pancreatic Malignancies:None

Sponsors

Mianyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years old; 2. Patients with pathologically or clinically confirmed hepatobiliary or pancreatic malignant tumors; 3. Patients can understand the content of this study and have the ability to follow up the study plan, sign the informed consent and volunteer to participate in this study.

Exclusion criteria

Exclusion criteria: The patient have cognitive impairment.

Design outcomes

Secondary

MeasureTime frame
patient reported outcomes;progression free survival;objective remission rate;Disease control rate;Treatment schedule change time;Equivalent morphine dose;—

Primary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactFeng Gao

Mianyang Central Hospital

edna_9999@163.com+86 18681630773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026